重磅药物-话题@MedSci

#重磅药物#

18篇内容 | 636人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1679635, encodeId=117b16e963586, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=3.5亿美元，阿斯利康出售重磅药物Crestor欧洲权益, objectType=article, longId=204104, objectId=cb44204104d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb44204104d5, replyNumber=0, likeNumber=49, createdTime=2021-01-26, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb44204104d5, moduleTitle=3.5亿美元，阿斯利康出售重磅药物Crestor欧洲权益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb44204104d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679636, encodeId=565716e963668, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=盘点 | 2020年专利到期10大重磅药物, objectType=article, longId=204849, objectId=a4e120484989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4e120484989, replyNumber=0, likeNumber=25, createdTime=2021-02-07, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4e120484989, moduleTitle=盘点 | 2020年专利到期10大重磅药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4e120484989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679634, encodeId=4fb616e963420, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=Cell：乳腺癌”网红“的朋友圈里，竟藏着让重磅药物失效的盾牌！, objectType=article, longId=135715, objectId=018b135e15ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=018b135e15ce, replyNumber=0, likeNumber=33, createdTime=2018-05-18, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=018b135e15ce, moduleTitle=Cell：乳腺癌”网红“的朋友圈里，竟藏着让重磅药物失效的盾牌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=018b135e15ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679631, encodeId=117216e9631b1, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=2017有望上市的15种重磅药物, objectType=article, longId=88330, objectId=d6688833081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6688833081, replyNumber=0, likeNumber=42, createdTime=2018-01-18, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6688833081, moduleTitle=2017有望上市的15种重磅药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6688833081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679633, encodeId=d1b816e963310, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=【BioWeek资讯回顾】柳叶刀公布35国公民预期寿命，10大重磅药物面临专利过期，肥胖可能是种传染病……, objectType=article, longId=90091, objectId=ff7690091dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff7690091dc, replyNumber=0, likeNumber=31, createdTime=2018-01-24, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff7690091dc, moduleTitle=【BioWeek资讯回顾】柳叶刀公布35国公民预期寿命，10大重磅药物面临专利过期，肥胖可能是种传染病……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff7690091dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679630, encodeId=8e5316e963080, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=Radius新型骨质疏松症药物abaloparatide III期临床获得成功，将成礼来重磅药物Forteo（特立帕肽）劲敌, objectType=article, longId=75431, objectId=5c87e54317c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c87e54317c, replyNumber=0, likeNumber=26, createdTime=2016-10-21, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c87e54317c, moduleTitle=Radius新型骨质疏松症药物abaloparatide III期临床获得成功，将成礼来重磅药物Forteo（特立帕肽）劲敌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c87e54317c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679632, encodeId=a55516e963270, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=2017，这10大重磅药物专利悬了！（礼来、吉利德、辉瑞、诺华……）, objectType=article, longId=89871, objectId=729f898e1b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=729f898e1b6, replyNumber=0, likeNumber=41, createdTime=2017-03-29, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=729f898e1b6, moduleTitle=2017，这10大重磅药物专利悬了！（礼来、吉利德、辉瑞、诺华……）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=729f898e1b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679628, encodeId=014516e9628d7, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=欧盟撤回百健多发性硬化重磅药物Tecfidera（通用名富马酸二甲酯）一项专利权, objectType=article, longId=68153, objectId=d17c68153ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d17c68153ab, replyNumber=0, likeNumber=37, createdTime=2016-09-12, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d17c68153ab, moduleTitle=欧盟撤回百健多发性硬化重磅药物Tecfidera（通用名富马酸二甲酯）一项专利权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d17c68153ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679629, encodeId=318f16e96293b, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=强生、诺华二季度报一起看：重磅药物贡献大！, objectType=article, longId=74004, objectId=6e71e4004b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e71e4004b6, replyNumber=0, likeNumber=36, createdTime=2016-12-11, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e71e4004b6, moduleTitle=强生、诺华二季度报一起看：重磅药物贡献大！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e71e4004b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679627, encodeId=930216e962742, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=Ardelyx重磅药物tenapanor（NHE3受体抑制剂）二期临床试验失利, objectType=article, longId=50383, objectId=d6d7503835f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6d7503835f, replyNumber=0, likeNumber=43, createdTime=2015-05-17, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6d7503835f, moduleTitle=Ardelyx重磅药物tenapanor（NHE3受体抑制剂）二期临床试验失利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6d7503835f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679626, encodeId=281516e962674, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, objectType=article, longId=48434, objectId=d5af48434cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5af48434cb, replyNumber=0, likeNumber=45, createdTime=2015-10-08, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5af48434cb, moduleTitle=诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5af48434cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679624, encodeId=9e9c16e962460, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险, objectType=article, longId=40984, objectId=53c6409848a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53c6409848a, replyNumber=0, likeNumber=43, createdTime=2014-10-25, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53c6409848a, moduleTitle=DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53c6409848a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679623, encodeId=4ad816e9623fa, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=即将结束临床试验的全球重磅药物TOP 15, objectType=article, longId=38983, objectId=aaff3898326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaff3898326, replyNumber=0, likeNumber=31, createdTime=2014-11-26, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaff3898326, moduleTitle=即将结束临床试验的全球重磅药物TOP 15, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaff3898326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679625, encodeId=ce3a16e962527, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=战胜癌症：光靠重磅药物可不行, objectType=article, longId=42632, objectId=087c42632ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=087c42632ae, replyNumber=0, likeNumber=42, createdTime=2015-01-27, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=087c42632ae, moduleTitle=战胜癌症：光靠重磅药物可不行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=087c42632ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679622, encodeId=090316e962257, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=吉利德重磅药物Zydelig治疗复发性CLL III期研究疗效获突破, objectType=article, longId=38255, objectId=ae0238255eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae0238255eb, replyNumber=0, likeNumber=34, createdTime=2014-11-07, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae0238255eb, moduleTitle=吉利德重磅药物Zydelig治疗复发性CLL III期研究疗效获突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae0238255eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679620, encodeId=ee8816e962053, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=辉瑞潜在重磅药物tofacitinib 2个III期研究达主要终点, objectType=article, longId=25277, objectId=4107252e7fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4107252e7fd, replyNumber=0, likeNumber=35, createdTime=2014-04-19, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4107252e7fd, moduleTitle=辉瑞潜在重磅药物tofacitinib 2个III期研究达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4107252e7fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679621, encodeId=99c216e96210b, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=2013年全球大药企重磅药物销售额一览, objectType=article, longId=30401, objectId=8ae43040103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae43040103, replyNumber=0, likeNumber=35, createdTime=2014-06-22, rootId=0, userName=qindq, userId=4bde27802965, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae43040103, moduleTitle=2013年全球大药企重磅药物销售额一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae43040103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679619, encodeId=5b4916e961949, content=<a href='/topic/show?id=2214960117d' target=_blank style='color:#2F92EE;'>#重磅药物#</a>, objectTitle=辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决, objectType=article, longId=5996, objectId=78a6599680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a6599680, replyNumber=0, likeNumber=38, createdTime=2012-06-10, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a6599680, moduleTitle=辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78a6599680)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重磅药物

2020-05-29

qindq (审核中...)

前往app查看评论内容

#重磅药物#

3.5亿美元，阿斯利康出售重磅药物Crestor欧洲权益

2021-01-26

qindq (审核中...)

前往app查看评论内容

#重磅药物#

盘点 | 2020年专利到期10大重磅药物

2021-02-07

qindq (审核中...)

前往app查看评论内容

#重磅药物#

Cell：乳腺癌”网红“的朋友圈里，竟藏着让重磅药物失效的盾牌！

2018-05-18

qindq (审核中...)

前往app查看评论内容

#重磅药物#

2017有望上市的15种重磅药物

2018-01-18

qindq (审核中...)

前往app查看评论内容

#重磅药物#

【BioWeek资讯回顾】柳叶刀公布35国公民预期寿命，10大重磅药物面临专利过期，肥胖可能是种传染病……

2018-01-24

qindq (审核中...)

前往app查看评论内容

#重磅药物#

Radius新型骨质疏松症药物abaloparatide III期临床获得成功，将成礼来重磅药物Forteo（特立帕肽）劲敌

2016-10-21

qindq (审核中...)

前往app查看评论内容

#重磅药物#

2017，这10大重磅药物专利悬了！（礼来、吉利德、辉瑞、诺华……）

2017-03-29

qindq (审核中...)

前往app查看评论内容

#重磅药物#

欧盟撤回百健多发性硬化重磅药物Tecfidera（通用名富马酸二甲酯）一项专利权

2016-09-12

qindq (审核中...)

前往app查看评论内容

#重磅药物#

强生、诺华二季度报一起看：重磅药物贡献大！

2016-12-11

qindq (审核中...)

前往app查看评论内容

#重磅药物#

Ardelyx重磅药物tenapanor（NHE3受体抑制剂）二期临床试验失利

2015-05-17

qindq (审核中...)

前往app查看评论内容

#重磅药物#

诺华重磅药物Jakavi欧盟收获新适应症：真性红细胞增多症（PV）

2015-10-08

qindq (审核中...)

前往app查看评论内容

#重磅药物#

DA确定罗氏/诺华哮喘重磅药物索雷尔（Xolair）提高心血管风险

2014-10-25

qindq (审核中...)

前往app查看评论内容

#重磅药物#

即将结束临床试验的全球重磅药物TOP 15

2014-11-26

qindq (审核中...)

前往app查看评论内容

#重磅药物#

战胜癌症：光靠重磅药物可不行

2015-01-27

爆笑小医 (审核中...)

前往app查看评论内容

#重磅药物#

吉利德重磅药物Zydelig治疗复发性CLL III期研究疗效获突破

2014-11-07

qindq (审核中...)

前往app查看评论内容

#重磅药物#

辉瑞潜在重磅药物tofacitinib 2个III期研究达主要终点

2014-04-19

qindq (审核中...)

前往app查看评论内容

#重磅药物#

2013年全球大药企重磅药物销售额一览

2014-06-22

docwu2019 (审核中...)

前往app查看评论内容

#重磅药物#

辉瑞潜在重磅药物tofacitinib下周面临FDA专家小组关键性表决

2012-06-10

科室
- - 订阅+
  - 更多科室
工具
服务